Inoue Kazuhide, Tsuda Makoto
Department of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
Glia. 2009 Nov 1;57(14):1469-79. doi: 10.1002/glia.20871.
In contrast to physiological pain, pathological pain is not dependent on the presence of tissue-damaging stimuli. One type of pathological pain--neuropathic pain--is often a consequence of nerve injury or of diseases such as diabetes, AIDS, or cancer. Neuropathic pain can be agonizing, can persist over long periods, and, unfortunately, is often resistant to known painkillers. There is a rapidly growing body of evidence indicating that microglia, the CNS immune cells, have causal roles in the pathogenesis of pain hypersensitivity following nerve injury. We will review recent advances in our understanding of the mechanisms producing neuropathic pain, focusing on the roles of microglia-expressed molecules, including cell surface receptors, intracellular signaling molecules, and diffusible factors involved in nerve injury-induced pain behaviors and hyperexcitability of dorsal horn neurons. Elucidating how spinal microglia cause neuropathic pain may provide us with exciting insights into pain mechanisms and clues for developing new drugs for the treatment of neuropathic pain.
与生理性疼痛不同,病理性疼痛并不依赖于组织损伤性刺激的存在。一种病理性疼痛——神经性疼痛——通常是神经损伤或糖尿病、艾滋病或癌症等疾病的结果。神经性疼痛可能令人痛苦,会长期持续,而且不幸的是,它往往对已知的止痛药有抗性。越来越多的证据表明,小胶质细胞(中枢神经系统免疫细胞)在神经损伤后疼痛超敏反应的发病机制中起因果作用。我们将综述我们对产生神经性疼痛机制的最新认识进展,重点关注小胶质细胞表达分子的作用,包括细胞表面受体、细胞内信号分子以及参与神经损伤诱导的疼痛行为和背角神经元兴奋性过高的可扩散因子。阐明脊髓小胶质细胞如何导致神经性疼痛,可能会为我们提供有关疼痛机制的令人兴奋的见解,以及开发治疗神经性疼痛新药的线索。